Kantonsspital St.Gallen

Sankt Gallen, Switzerland

9 recruiting

Showing 118 of 18 trials

Recruiting

Bleeding of Unknown Cause: a Swiss Case-control Study

Bleeding Disorder
University Hospital, Geneva400 enrolled7 locationsNCT05713734
Recruiting
Phase 3

A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

Interstitial Lung DiseasesSystemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases
Boehringer Ingelheim400 enrolled158 locationsNCT06806592
Recruiting

Swiss National Registry of Adults With Congenital Heart Disease

congenital heart defectCongenital Heart Disease
University Hospital, Basel, Switzerland5,000 enrolled6 locationsNCT02258724
Recruiting
Phase 2

A Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2

Extensive Stage Lung Small Cell Cancer
ETOP IBCSG Partners Foundation48 enrolled19 locationsNCT07203053
Recruiting
Phase 1

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Diffuse Large B-Cell Lymphoma (DLBCL)Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)+6 more
Nurix Therapeutics, Inc.572 enrolled62 locationsNCT05131022
Recruiting

Determining Postoperative Recovery and the Impact of Adverse Events in Neurosurgery Based on Self-reported, App-based Longitudinal Assessment

Brain TumorDisc DiseaseInstabilities Lumbar+1 more
Cantonal Hospital of St. Gallen400 enrolled1 locationNCT06352710
Recruiting
Phase 3

A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer.

Non-small Cell Lung Cancer
ETOP IBCSG Partners Foundation290 enrolled42 locationsNCT06284317
Recruiting

Targeting Real World Usage In Stroke Treatment

StenosisPseudoaneurysmSaccular and Fusiform Aneurysms+6 more
Phenox GmbH5,000 enrolled13 locationsNCT07474935
Recruiting

DESTINY Breast Respond HER2-low Europe

Metastatic Breast CancerUnresectable Breast CancerHER2-low Expressing Breast Cancer
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1,155 enrolled211 locationsNCT05945732
Recruiting
Phase 2

NEODOXy: Targeting Breast Cancer Stem Cells With Doxycycline

Breast Cancer
Swiss Cancer Institute50 enrolled8 locationsNCT06452394
Recruiting
Phase 3

Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients

Melanoma Stage IIIBMelanoma Stage IIICMelanoma Stage IIID
Philogen S.p.A.186 enrolled37 locationsNCT03567889
Recruiting

Swiss Autoimmune Hepatitis Cohort Study

Autoimmune HepatitisHepatitis, Autoimmune
Fondazione Epatocentro Ticino500 enrolled20 locationsNCT03146884
Recruiting

Swiss Primary Sclerosing Cholangitis Cohort Study

Primary Sclerosing Cholangitis (PSC)Cholangitis, SclerosingPSC
Fondazione Epatocentro Ticino120 enrolled21 locationsNCT03146936
Recruiting

Swiss Primary Biliary Cholangitis Cohort Study

Primary Biliary CholangitisPBC
Fondazione Epatocentro Ticino500 enrolled13 locationsNCT03146910
Recruiting
Not Applicable

A Space-expanding Shield in Decompressive Hemicraniectomy for Stroke

Stroke
Insel Gruppe AG, University Hospital Bern110 enrolled6 locationsNCT06638385
Recruiting
Phase 3

Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer

Prostate Cancer
Gustave Roussy, Cancer Campus, Grand Paris1,210 enrolled23 locationsNCT03819101
Recruiting

Post-Market BTVA Registry

Emphysema or COPD
Uptake Medical Technology, Inc.300 enrolled20 locationsNCT03318406
Recruiting

Incidence of Silent Atrial Fibrillation in Patients With Clinically Silent Brain Ischemic Lesions

Silent StrokeSilent Cerebral InfarctFibrillation
Insel Gruppe AG, University Hospital Bern150 enrolled8 locationsNCT04449523